医疗ETF（159828）连续5日迎净流入，支持政策或将持续加强

Group 1 - The core viewpoint is that recent policies from Beijing and Shanghai are expected to strengthen government support for innovative medical devices, leading to accelerated innovation in the sector [1] - Companies in the medical device industry are anticipated to experience performance and valuation recovery opportunities in 2026, with several leading firms in niche segments expected to see accelerated growth [1] - The medical ETF (159828) tracks the CSI Medical Index (399989), which includes listed companies in the medical and pharmaceutical retail sectors, reflecting the overall performance of related securities [1] Group 2 - The CSI Medical Index primarily covers areas such as medical devices, medical services, and medical research outsourcing, and is characterized by a bias towards small and mid-cap stocks with high growth potential and volatility [1]